39th Annual International Meeting

August 26 - 30, 2001
Prague, Czech Republic

Sunday, August 26

14.00 - 18.00

REGISTRATION

14.30 - 15.30

International Scientific and Organizing Committees Meeting

15.30 - 16.30

Meeting of TIAFT Regional Representatives

19.00 - 22.00

WELCOME RECEPTION - Carolinum (Ovocny Trh 3)

Monday, August 27

  8.00 - 18.00

REGISTRATION

  9.00 - 11.30

OPENING CEREMONY
 

PL1

PL2

11.30

LUNCH BREAK
 

13.00 - 18.00

FORENSIC TOXICOLOGY
Chairpersons: M.D. Osselton (U.K.), A. Ishii (Japan), T. Daldrup (Germany), M. Kala (Poland)
 

L1

Key Note Lesson:
M.D. Osselton:
Forensic Toxicology
 

L2

R.J. Flanagan, C. Rooney:
Recording Acute Poisoning Deaths
 

L3

P. Holmgren, K. Melinder, A. Holmgren, J. Ahlner, H. Druid:
Presence of Alcohol and Drugs in Drowning Victims
 

L4

A. W. Jones:
Pharmacokinetics of Ethanol in Arterial and Venous Blood
 

L5

J. P. Goullé, Ch. Lacroix, D. Bouige:
Glycated Haemoglobin: A Marker of Interest in Forensic Cases
 

L6

C.W. Lee, J.C.N. Tam:
Determination of Carboxyhaemoglobin in Putrefied Blood and Cavity Fluid
 

L7

F.A. De Wolff, K. Berend, G.B. Van Der Voet:
Subacute Lethal Aluminium Intoxication in Dialysed Patients Due to Cement Mortar Piping
 

L8

A. Negrusz, P.J. Goldstein, P.S. Levy:
Estimate of the Incidence of Drug-facilitated Sexual Assault in the United States
 

L9

T. St.Claire, M.A. ElSohly, S.J. Salamone, L.F. Lee, L.B. Holzhauer:
The Final Report on the Prevalence of Drugs Used in Alleged Cases of Sexual Assault
 

L10

S. Athanaselis, S. Papadodima, A. Dona, G. Papoutsis, A. Koutselinis:
Drug Related Deaths in Greece: A Six Year Survey (1995-2000)
 

COFFEE BREAK, INFORMAL POSTER SESSION, EXHIBITIONS
 

L11

E.T. Shimomura, B.D. Paul:
Postmortem Examination of Body Fluids and Tissues for the Presence of Smoked Cocaine, Pyrolytic Methylecgonidine, and Their Metabolites by GC-MS-SIM Method
 

L12

A. Hodda, M. Collins, M. Dawson, T.H. Quoc:
Investigation of Unusually High Delta-9 THC Levels in Post Mortem Blood
 

L13

J. Gerostamoulos, P.J. McCaffrey, O.H. Drummer:
The Use of ELISA (Enzyme-Linked Immunosorbent Assay) Screening in Postmortem Blood
 

L14

K. Takaichi, N.P. Lemos, R.A. Anderson:
Analysis of Opiates in Nail Clippings from Chronic Heroin Abusers
 

L15

T. Decaestecker, K. Clauwaert, E. De Letter, M.P. Bouche, W. Lambert, J. Van Bocxlaer, M. Piette, E. Van Den Eeckhout, C. Van Peteghem, A. De Leenheer:
Fatal 4-MTA Intoxication: Development of a Liquid Chromatographic - Tandem Mass Spectrometric Assay for Multiple Matrices
 

L16

V. Dumestre-Toulet, V. Cirimele, B. Ludes, T. Beloussof, S. Gromb, P. Kintz:
Last Performance with Sildenafil (Viagra®)
 

L17

M. Klys, B. Bujak-Gizycka, B. Bystrowska:
The Use of LC/MS Method to Document Postmortem Redistribution of Drugs and Their Metabolites: Examples of Fatal Poisonings with Verapamil and Levomepromazine
 

L18

S. Hallander:
Difficulties in Interpreting Post Mortem Toxicology: Citalopram as an Example
 

L19

D. Borrey, T. Benijts, W.E. Lambert, M.H. Piette, C. Van Peteghem, A.P. De Leenheer:
A Fatal Case of Flecainide Intoxication
 

L20

J.M. Franco, S. Fonseca, S. Costa, M.J. Dias, F.S. Ferreira, N. Goncalves:
The Advantage of HPLC Sample Clean - Up in the Confirmation and Quantitation of Low Level Concentration Drugs in Complex Matrices
 

L21

M.R. Baumgartner, P.X. Iten:
Rapid Death after Transdermal Hydrofluoric Acid Intoxication
 

20.00

CONCERT (St. Nicolas Church in Lesser Town Square)

Tuesday, August 28

  8.00 - 18.00

REGISTRATION

  8.30 - 10.00

CLINICAL TOXICOLOGY
Chairpersons: H.H. Maurer (Germany), D.R.A. Uges (The Netherlands)
 

L22

Key Note Lesson:
H.H. Maurer:
What Is the Appropriate Analytical Strategy for Effective Management of Intoxicated Patients?

 

L23

J.P. Goullé, V. Gembus, Ch. Lacroix:
Determination of Glycols in Biological Specimens by Gas Chromatography-Mass Spectrometry
 

L24

M.A. Martínez, C. Sánchez De La Torre, E. Almarza:
Simultaneous Determination of Viloxazine, Venlafaxine, Imipramine, Desipramine, Sertraline and Amoxapine in Whole Blood: Comparison of Two Extraction / Clean-up Procedures for Capillary Gas-liquid Chromatography with Nitrogen-phosphorus Detection
 

L25

R. Dams, T. Benijts, W.E. Lambert, A.P. De Leenheer: Simultaneous Determination of in Total Seventeen Opium Alkaloids and Opioids in Blood and Urine by Fast HPLC-DAD-FL Detection, after Solid-phase Extraction
 

L26

T. Grobosh, U. Lemm-Ahlers:
Immunoassay Screening of Lysergic Acid Diethylamide (LSD) in Urine and its Confirmation by HPLC with Fluorescence Detection after Immunelute Extraction
 

L27

J.H. Lewis, P. Bowron:
Viability of a Buprenorphine ELISA Assay in Monitoring Patient Compliance in Drug Substitution Treatment
 

L28

V. Cirimele, P. Kintz, S. Lohner, B. Ludes:
Evaluation of the Microgenics Buprenorphine Urine Assay Versus LC-ES-MS
 

10.00 - 10.30

COFFEE BREAK
 

10.30 - 12.30

NEW ANALYTICAL TECHNOLOGIES
Chairpersons: A. Polettini (Italy), I. Ojanpera (Finland)
 

L29

Key Note Lesson:
A. Polettini:
New Analytical Technologies in Toxicology
 

L30

F. Bortolotti, M. Zuliani, G. Manetto, F. Cittadini, F. Tagliaro:
A New Tool for the Objective Diagnosis of Chronic Alcohol Abuse: The Determination of Carbohydrate-deficient Transferrin (CDT) with Capillary Electrophoresis
 

L31

K. Asri, R.A. Anderson:
Determination of Benzodiazepines in Urine by Solid Phase Microextraction and Gas Chromatography with Nitrogen Phosphorus Detection
 

L32

F. Musshoff, D. Lachenmeier, L. Kröner, B. Madea:
Automated Headspace Solid-phase Dynamic Extraction (SPDE) - First Experience with a New Technique
 

L33

A. Ishii, R. Kurihara, K. Watanabe-Suzuki, H. Seno, T. Kumazawa, O. Suzuki, Y. Katsumata:
Sensitive Determination of Pethidine in Human Body Fluids by Gas Chromatography / Tandem Mass Spectrometry (GC/MS/MS)
 

L34

C. Kratsch, A.A. Weber, T. Kraemer, H.H. Maurer:
Screening, Identification and Quantification of Nine Oral Antidiabetics of the Sulfonylurea-type in Plasma by APCI-LC-MS
 

L35

C.M. Cuppett, M.R. Jackson, M.P. Balogh, F. Grisel, G. Bondoux:
Automated, Integrated PDA and MS Library Searching for the Identification of Forensic Samples
 

L36

L. Rivier:
Robustnes Evaluation for Automatic Identification of General Unknown by Reference ESI Mass Spectra Comparison in LC-MS Toxicological Screening
 

L37

M. Gergov, A. Pelander, I. Ojanperä, E. Vuori:
Toxicological Screening of Urine for Drugs by LC/TOFMS with Automated Target Library Search
 

12.30

LUNCH BREAK
 

14.00 - 16.00

DOPING & DRUGS OF ABUSE
Chairpersons: J. Segura (Spain), A. Pierce (Ireland)
 

L38

Key Note Lesson:
J. Segura:
Doping in Sports Testing
 

L39

V.P. Uralets, P.A. Gilette:
Long Term Detection of Anabolic Steroids Abuse in Urine. Longevity of Sulfate Conjugated Metabolites
 

L40

L. Amendola, C. Colamonici, F. Rossi, F. Botré:
Determination of Clenbuterol in Human Urine by GC-MS-MS-MS: A Confirmation Analysis in Antidoping Control
 

L41

P. Kintz, V. Cirimele, J.S. Raul, J.P. Goullé, B. Ludes:
Alternative Doping Control for Corticoids by Hair Analysis with LC/MS
 

L42

M. Deveaux, E. Mornay, D. Gosset:
Physiological Values of Testosterone in Hair: Determination by Radioimmunoassay, Usefulness in Doping Control
 

L43

S.W. Toennes, V. Kraus, G.F. Kauert:
Studies on the Hepatic Metabolism of Cocaine Using Isolated Serum-free Rat Liver
 

L44

N.T. Lu, B.G. Taylor, K.J. Riley:
Monitoring the Crack Epidemic Through Urinalysis and Examining the Validity of Crack Self-reports
 

L45

R. F. Staack, G. Fritschi, H.H. Maurer:
GC-MS Studies on the Metabolism and on the Toxicological Analysis of the New Piperazine-like Designer Drugs BZP, MDBP, TFMPP, MCPP, MEOPP
 

L46

D. Springer, F.T. Peters, G. Fritschi, H.H. Maurer:
Studies on the Metabolism of the New Pyrrolidino-propiophenone Designer Drugs MPPP and MDPPP
 

16.00

COFFEE BREAK

16.30

OFFICIAL POSTER SESSION, EXHIBITIONS

16.30

Young Scientist Meeting

16.30

European DoA Survey Coordinators Meeting

Wednesday, August 29

9.00 WHOLE DAY EXCURSION
Glass Factory Tasice and Cesky Sternberk Castle

Thursday, August 30

  8.00 - 18.00

REGISTRATION

  8.30 - 10.00

ALTERNATIVE SPECIMEN
Chairpersons: V. Spiehler (USA), P. Kintz (France)
 

L47

Key Note Lesson:
V. Spiehler:
Alternative Specimen Testing
 

L48

G.M. Abd-El-Azzim, R.A. Anderson, L. Jackson, C.H. Skeoch, S. Williamson:
Survey of Illicit Drug Use During Pregnancy in the Glasgow Area, Based on Meconium Analysis
 

L49

A. Wong, O.A. Silva:
Cocaine, Marijuana, Amphetamines and Opiates in the Hair, Urine and Meconium of Low Birth Weight Neonates and Their Correlation with the Hair and Urine of the Mothers
 

L50

C. Jurado, M.P. Giménez, M. Menéndez, M. Repetto:
Simultaneous Determination of Amphetamine and Cannabis Compounds in Hair
 

L51

N. Samyn, G. De Boeck, V. Cirimele, P. Kintz:
Controlled Study of Flunitrazepam in Saliva
 

L52

E.J. Cone, R.S. Niedbala, K.W. Kardos, D.F. Fritch:
Is There a Link Between Δ-9-tetrahydrocannabinol (THC) in Oral Fluid and Plasma?
 

L53

T. Foley, G. Liang, G. Wang, D. Nam, C. Chang, A. Avila, T. Tusak, C. Caro, L. Shelton, F. Westhout:
A Novel Method for the Detection of Drugs of Abuse in Oral Fluids
 

L54

Key Note Lesson:
M. Moeller:
Drugs and Driving
 

L55

A. Verstraete:
Roadside Drug Testing: the Results of the Rosita Project
 

L56

O.H. Drummer, J. Gerostamoulos:
Cannabis and the Risk of Road Crashes
 

L57

N. Samyn, G. De Boeck, D. De Waard, K. Brookhuis, C. Lamers, W. Riedel, M. Wood, M. Morris:
Driving Under the Influence of Ecstasy: Toxicological Data in Controlled and Real Life Conditions
 

L58

G. Skopp, L. Potsch:
A Simple Approach to Detect Cocaine in Forensic Drug Analysis
 

L59

N. Goncalves, J.M. Franco, S. Fonseca, S. Costa, F.S. Ferreira, M.J. Dias:
Validation of Analytical Methods According to Permitted Levels Defined by Portuguese Legislation for Driving Under the Influence of Alcohol and/or Drugs of Abuse
 

L60

M. Vevelstad, J. Morland:
Breath Alcohol Measurements and Mouth Alcohol
 

L61

J. Ahlner, P. Holmgren:
Alcohol and Drugs in Deceased Drivers in Sweden
 

12.00

LUNCH BREAK
 

13.00 - 14.30

WORKPLACE DRUG TESTING & DRUGS OF ABUSE
Chairpersons: A. Verstraete (Belgium), E.J. Cone (USA)
 

L62

Key Note Lesson:
A. Verstraete:
Workplace Drug Testing
 

L63

P. Björklöv, A. Pierce, J. Pinheiro:
Comparison Between Attitudes to Workplace Drug Testing in Ireland, Portugal and Sweden
 

L64

J. Zamecnik, P. Tikuisis, O.R. Hung, P. Shek:
Plasma Concentrations and Tissue Distribution of Pulmonary Administered Liposomal Tetrahydrocannabinol (Δ9-THC)
 

L65

T. Kraemer, N.M. Kneller, F.T. Peters, H.H. Maurer:
CYP2D6 Polymorphism Is Not Crucial to the N-dealkylation of Amphetamine Derivatives: In-vitro Studies Using Rat and Human Liver Microsomes
 

L66

J.S.-C. Tsai, B. Oades, D. Demirtzoglou, H. Zhao, S. Salamone:
Simultaneous Evaluation of Ontrak Teststik Amphetamines Assay and Teststik Methamphetamine Assay for the Screening of Amphetamines in Urine
 

L67

F.T. Peters, T. Kraemer, H.H. Maurer:
Sensitive NICI-GC-MS Assay for Determination of Amphetamine and Methamphetamine Enantiomers in Human Blood: Development and Application in Toxicological Cases
 

L68

D.R.A. Uges:
What Can We, TIAFT Members, Do Against Drugs?
 
 

14.30 - 16.00

EQAS IN TOXICOLOGY
Chairpersons: J.F. Wilson (U.K.), B. Widdop (U.K.)
 

L69

Key Note Lesson:
J.F. Wilson:
External Assurance Schemes for Toxicology
 

L70

O.H. Drummer, J.H. Lewis:
Proficiency Programs and Accreditation in Forensic Toxicology: The Australian Experience
 

L71

D.R.A. Uges:
The Aim of the Dutch KKGT: Quality Assessment and Education in TDM and in Clinical and Forensic Toxicology
 

L72

P. Lillsunde, A.R. Vanhanen:
Labquality External Quality Assurance Schemes for Drugs of Abuse
 

L73

R.E. Aderjan, M. Herbold:
Interlaboratory Comparison on the Determination of Cannabinoids: Spiked Serum Versus a "Real" Blood Specimen (GTFCH Forensic Toxicology Ring-tests)
 

L74

M. Montagna, A. Polettini, C. Stramesi, A. Groppi, C. Vignali:
Hair Analysis for Opiates, Cocaine and Metabolites: Evaluation of a Method by Interlaboratories Comparison
 

L75

R. Aderjan, M. Herbold, I. Dijkhuis, B. Widdop:
Quality Assurance Concepts and Interlaboratory Comparison by Collaborative European Drugs of Abuse Testing for Clinical, Work Place and Forensic Purposes - Results of the 2001 (2nd) Ring-test
 

16.00

COFFEE BREAK

16.15 - 18.00

TIAFT Business Meeting

20.00 - 24.00

CLOSING BANQUET (Palace Zofin)